Physician profile
Taylor B Cates
NPI 1427216449
$1,295.29
in general payments reported to CMS, 2019-2025
25 companies · $80.48 in 2025
The $80.48 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $136 · 2021: $101 · 2022: $96.96 · 2023: $153 · 2024: $314 · 2025: $80.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $251.65 | 2019-2024 | Iconix, Na, Gamma |
| Horizon Therapeutics Plc | $137.46 | 2019-2022 | |
| Depuy Synthes Sales INC. | $127.91 | 2019-2022 | |
| Pacira Therapeutics, INC. | $107.70 | 2019-2021 | |
| Bioventus LLC | $94.85 | 2019-2025 | Durolane |
| Ermi LLC | $92.98 | 2020-2024 | |
| Ethicon US, LLC | $61.55 | 2024 | Vistaseal |
| Restor3d, INC. | $59.92 | 2023 | |
| Illuminoss Medical, INC. | $54.32 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Vertos Medical, INC. | $45.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.94 | 2019 | |
| Davol INC. | $30.17 | 2025 | |
| Biosense Webster, INC. | $19.71 | 2023 | Carto 3 |
| Heron Therapeutics, INC. | $19.42 | 2023 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $18.01 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $17.56 | 2019 | |
| Endo USA, INC. | $15.23 | 2025 | Xiaflex |
| Zyla Life Sciences, INC. | $14.69 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.23 | 2025 | Zilretta |
| Acera Surgical, INC. | $14.06 | 2019 | |
| Vericel Corporation | $13.78 | 2021 | |
| Smith+Nephew, INC. | $12.20 | 2022 | |
| Polarityte, INC. | $11.42 | 2019 | |
| Kerecis Limited | $11.16 | 2022 | |
| Orthofix Medical, INC. | $4.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Cates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.